Screener Summaries Updates Institutions Sign In More Updates › Other Events › AEMD Other Events · Oct 9, 2026
Stockholders approve increasing authorized common shares from 20M to 200M AEMD Aethlon Medical Inc
Aethlon Medical stockholders approved an amendment to the Articles of Incorporation at the October 1, 2026 annual meeting to increase the number of authorized common shares from 20 million to 200 million. The amendment was filed with the Secretary of State of Nevada and became effective on October 7, 2026. Aethlon Medical develops medical devices for blood purification.
More from Aethlon Medical Inc Stockholders reject proposal to authorize 20M shares of preferred stock Oct 5, 2026 Aethlon agrees to merge with North Immunology in all-stock deal; $180M PIPE closes Sep 17, 2026 Aethlon Medical reported fiscal first quarter results for the period ended June 30, 2026 Aug 13, 2026 Aethlon Medical, Inc. filed a Certificate of Change with the Nevada Secretary of State on July 30, 2026, authorizing a… Jul 31, 2026 Aethlon Medical, Inc. entered into a Securities Purchase Agreement on July 6, 2026, to conduct a registered public… Jul 7, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
